Resorcinol pp 179-227 | Cite as

Pharmaceuticals, Over-the-Counter Medications, and Diagnostic Aids

  • Hans Dressler
Part of the Topics in Applied Chemistry book series (TAPP)

Abstract

The above index indicates that the resorcinol moiety appears in a considerable variety of pharmaceuticals and related materials, both older and relatively new products. The sources of these products are either synthesis from resorcinol, 1,3-cyclohexanedione (dihydroresorcinol), or m-aminophenol, or extraction of natural or fermentation products; many modifications of these techniques are employed. Indeed, the development of some of these commercial compounds was based on the modification of natural products to minimize undesirable side effects and to shape and maximize the therapeutic properties. It is not possible to describe the details of the manufacturing processes of the commercial materials here; these details are available in the primary literature.

Keywords

Penicillanic Acid American Cyanamid American Home Product Yamanouchi Pharmaceutical Resorcinol Moiety 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Chem. Ind. (London), 1992 (5), 1963.Google Scholar
  2. 2.
    D. A. Lewis, Chem. Brit, 28, 143 (1992).Google Scholar
  3. 3.
    Fed. Regist., 16 Aug. 1991, 56 (159), 41008-203.Google Scholar
  4. 4.
    G. W. Parshall and W. A. Nugent, Chemtech, 1988 (6), 382.Google Scholar
  5. 5.
    W. S. Marshall, T. Goodson, G. J. Cullinan, D. Swanson-Bean, K. D. Haisch, L. E. Rinkema, and J. H. Fleisch, J. Med. Chem., 30, 682 (1987).CrossRefGoogle Scholar
  6. R. D. Dillard, F. P. Carr, D. McCullough, K. D. Haisch, L. E. Rinkema, and J. H. Heisch, ibid., 30, 911 (1987).Google Scholar
  7. F. J. Brown, P. R. Bernstein, L. A. Cronk, D. L. Dossett, K. C. Heel, T. P. Maduskuie, Jr., H. S. Shapiro, E. P. Vacek, Y. K. Yee, A. K. Willard, R. D. Krell, and D. W. Snyder, ibid, 32, 807 (1989).Google Scholar
  8. 6.
    Chem. Eng. News, 70, Aug. 31, 1992, 113.Google Scholar
  9. 7.
    Jpn. Kokai Tokkyo Koho JP 80,036,428 (March 14, 1980; H. Munakata, T. Tsutsui, S. Sato, K. Honda, M. Kobayashi, and K. Azuma to Mitsubishi Chemical Industries Co., Ltd.); C.A., 94, 66064 (1981).Google Scholar
  10. 8.
    Brit. UK Pat. Appl. GB 2,037,740 (July 16, 1980; M. Takashima, S. Iwanami, and S. Usuda to Yamanouchi Pharmaceutical Co., Ltd.); C.A., 94, 15673 (1981).Google Scholar
  11. 9.
    U.S. Pat. 4,225,619 (Sept. 30, 1980; R. Brickl, H. Eberhardt, K.-R. Appel, U. Lechner, and W. Merk to Boehringer Ingelheim G.m.b.H.).Google Scholar
  12. 10.
    Eur. Pat. Appl. EP 17195 (Oct.15, 1980; S. Hamane, S. Kitamura, and Y. Nakajima to Eisai Co., Ltd.); C.A., 95,103336 (1981).Google Scholar
  13. 11.
    Neth. Appl. NL 79,001,466 (Aug. 26, 1980; to Agence Nationale de Valorisation de la Researche); C.A., 94, 103336 (1981).Google Scholar
  14. 12.
    U.S. Pat. 4,207,343 (June 10, 1980; E. R. Lavignio, L. J. McShane, and B. B. Molloy to Eli Lilly and Co.).Google Scholar
  15. 13.
    U.S. Pat. 4,228,079 (Oct. 14, 1980; G. J. Calton to W. R. Grace and Co.).Google Scholar
  16. 14.
    Ger. Offen. DE 3,031,788 (March 12, 1981; M. Shinohara, H. Kaise, Y. Nakano, T. Izawa, Y. Oshiro, and W. Miyazaki to Otsuka Pharmaceutical Co., Ltd.); C.A., 95, 81275 (1981).Google Scholar
  17. 15.
    U.S. Pat. 4,273,715 (June 16, 1981; R. T. Buckler and J. F. Burd to Miles Laboratories, Inc.).Google Scholar
  18. 16.
    U.S. Pat. 4,294,847 (Oct. 13, 1981; K. D. Kaufmann to T. C. Elder, Inc.).Google Scholar
  19. 17.
    Eur. Pat. Appl. EP 28,063 (May 6, 1981; A. W. Oxford and F. Ellis to Glaxo Group, Ltd.); C.A., 96, 34874(1982).Google Scholar
  20. 18.
    U.S. Pat. 4,305,938 (Dec. 15, 1981; H. E. Zaugg to Abbott Laboratories); see also H. E. Zaugg and J. Kynel, J. Med. Chem., 26(2), 214 (1983).Google Scholar
  21. 19.
    U.S. Pat. 4,252,818 (Feb. 24,1981; J. Rokach, P. A. Hamel, and R.F. Hirschman to Merck and Co., Inc.).Google Scholar
  22. 20.
    Austrian Pat. 361,483 (March 10, 1981; to Fisons, Ltd.); C.A., 95, 7252 (1981).Google Scholar
  23. 21.
    Jpn. Kokai Tokkyo Koho JP 81,095,164 (Aug. 1, 1981; to Kumiai Chemical Industry Co., Ltd.); C.A., 96, 6429 (1982).Google Scholar
  24. 22.
    Jpn. Kokai Tokkyo Koho JP 82,032,275 (Feb. 20, 1982; to Nippon Shinyaku Co., Ltd.); C.A., 96, 217880(1982).Google Scholar
  25. 23.
    Jpn. Kokai Tokkyo Koho JP 82,075,956 (May 12, 1982; to Torn and Co., Ltd.); C.A., 97, 163507 (1982).Google Scholar
  26. 24.
    Eur. Pat. Appl. EP 55,524 (July 7, 1982; E. A. Watts to Beecham Group PLC); C.A., 97, 215785 (1982).Google Scholar
  27. 25.
    U.S. Pat. 4,327,028 (Apr. 27, 1982; W. C. Kaplan to Calcol, Inc.).Google Scholar
  28. 26.
    Eur. Pat. Appl. EP 62,018 (Oct. 6, 1982; J. A. B. Engel, U. A. Hacksell, J. S. M. Hjorth, P. L. Lindberg, A. H. Mattson, J. L. G. Nilsson, D. Sanchez, et al. to Aktiebolag Haessle); C.A., 98, 71946 (1983).Google Scholar
  29. 27.
    Jpn. Kokai Tokkyo Koho JP 57,209,281 [82,209,281] (Dec. 22, 1982; to Otsuka Pharmaceutical Co. Ltd.); C.A., 98, 143437 (1983).Google Scholar
  30. 28.
    U.S. Pat. 4,351,840 (Sept. 28,1982; D. K. Pirie to Pfizer, Inc.).Google Scholar
  31. 29.
    Eur. Pat. Appl. EP 81,621 (June 22, 1983; E. S. C. Wu to Pennwalt Corp.); C.A., 99, 139772 (1983).Google Scholar
  32. 30.
    Eur. Pat. Appl. EP 80,371 (June 1, 1983; A. Nohara and Y. Maki to Takeda Chemical Industries, Ltd.); C.A., 99, 194621 (1982).Google Scholar
  33. 31.
    Eur. Pat. Appl. EP 83,228 (July 6, 1983; P. R. Bernstein and A. K. Willard to ICI Americas, Inc.); C.A., 99, 194624(1983).Google Scholar
  34. 32.
    Ger. Offen. DE 3,312,675 (Oct. 13, 1983; M. Carson, R. A. Lemahieu, and W. C. Nason to F. Hoffmann-LaRoche and Co., A.-G.); C.A., 100, 51267 (1984).Google Scholar
  35. 33.
    Rom. RO 83,980 (May 30, 1984; E. R. Bozga, F. I. Cunescu, and S. Ciliani-Bibian to Istitutul de Cercetari Chimico-Farmaceutice); C.A., 102, 148898 (1985).Google Scholar
  36. 34.
    A. N. Grinev, G. N. Pershin, L. F. Stebaeva, I. S. Nikoleva, V. I. Shvedov, I. A. Kharizomenova, and E. M. Botkina, Khim.-Farm. Zh., 18(3), 374 (1984); C.A., 101, 72359 (1984). USSR SU 1,114,422 (Sept. 23, 1984; G. N. Pershin, V. I. Shvedov, E. N. Sytina, A. N. Grinev, T. A. Gusikova, and A. L. Mikerina to S. Ordzhonikidze, All-Union Scientific-Research Chemical-Pharmaceutical Institute [CA., 102,32248 (1985)]—this patent claims Riodoxol as an antifungal agent; USSR SU 1,029,451 (March 7, 1985; A.P. Khrunova, T.A. Korchevaya, E. V. Vyborova, G. N. Pershin, N. S. Bogdanova, and I. S. Nikolaeva to Moscow Scientific-Research Institute/Chemical/Pharmaceutical Institute) [C.A., 102, 215175 (1985)]—this patent claims triiodoresorcinol as an antibacterial agent.Google Scholar
  37. 35.
    Ger. Offen. DE 3,125,059 (Jan. 5, 1983; H. Boeshagen, U. Hoerlein, G. Reinhard, F. Seuter, and E. Perzborn to Bayer A.-G.); C.A., 98, 106960 (1983).Google Scholar
  38. 36.
    Span. Pat. ES 516,736 (Oct. 1, 1983; A. F. Foguet, J. A. Ortiz Hernandez, L. Anglada Burniel, and A. Sacristan Munoz to Ferrer International, S.A.); C.A., 100, 138775 (1984).Google Scholar
  39. 37.
    Eur. Pat. Appl. EP 89,634 (Sept. 28, 1983; Y. Aoyagi, T. Okubo, T. Tomita, H. Nishida, and H. Enomoto to Nippon Shinyaku Co., Ltd.); C.A., 100, 51240 (1984).Google Scholar
  40. 38.
    Ger. Offen. DE 3,416,230 (Nov. 8,1984; R. A. LeMahieu to F. Hoffmann-LaRoche and Co., A.-G.); C.A., 102, 113083(1985).Google Scholar
  41. 39.
    P. Lumme, H. Elo, and J. Janne, Inorg. Chim. Acta, 92(4), 241 (1984); see also ibid., 107(2), L15-L16 (1985).CrossRefGoogle Scholar
  42. 40.
    U.S. Pat. 4,456,612 (June 26, 1984; J. J. Plattner and A. K. Fung to Abbbott Laboratories).Google Scholar
  43. 41.
    Eur. Pat Appl. EP 108,592 (May 16, 1984; W. S. Marshall and J. P. Verge to Eli Lilly and Co.); C.A., 101, 171258 (1984).Google Scholar
  44. 42.
    Eur. Pat. Appl. EP 112,587 (July 4, 1984; E. Toth, J. Torley, G. Fekete, L. Szporny, L. Vereczkey, E. Palosi, L. Kleborich, P. Vittay, S. Gorog, and I. Hajdu to Gideon Richter, Vegyeszeti Gyar Rt); C.A., 102, 5915(1985).Google Scholar
  45. 43.
    Eur. Pat. Appl. EP 126,342 (Nov. 28, 1984; J. A. Parks and J. J. Plattner to Abbott Laboratories); C.A., 102, 149250 (1985).Google Scholar
  46. 44.
    Eur. Pat Appl. EP 101,004 (Feb. 22, 1984; M. Matsumoto and N. Watanabe to Sagami Chemical Research Center); C.A., 101, 23331 (1984). A different process, also starting from 1,3-cyclohex-anedione, is described in Jpn. Kokai Tokkyo Koho JP 59,144,758 [84,144,758] (Aug. 8,1984; to Ube Industries, Ltd.); C.A., 102, 62078 (1985).Google Scholar
  47. 45.
    Eur. Pat Appl. EP201/751 (Nov.20, 1986; J.R. Fino and M.T. Shipchandler to Abbott Laboratories); C.A., 106, 192343 (1987).Google Scholar
  48. 46.
    U.S. Pat. 4,550,172 (Oct 29, 1975; J. H. Musser and C. O. Tio to American Home Products Co.).Google Scholar
  49. 47.
    Eur. Pat. Appl. EP 129,906 (Jan. 2, 1985; N. Cohen and G. F. Weber to Hoffmann-LaRoche and Co., A.-G.); C.A., 103, 62235 (1985).Google Scholar
  50. 48.
    U.S. Pat. 4,557,862 (Dec. 10, 1985; W. F. Mangel, S. Leytus, and L. L. Melhado to University Patents, Inc.).Google Scholar
  51. 49.
    Eur. Pat. Appl. EP 163,227 (Dec. 4, 1985; T. S. Abram, P. Norman, and B. T. Warren to Miles Laboratories, Inc.); C.A., 105, 97312 (1985).Google Scholar
  52. 50.
    USSR Pat. SU 780,435 (Feb. 28, 1985; A. A. Akhrem, F. A. Lakhvich, and T. S. Khlebnikova to Institute of Bioorganic Chemistry, Belorussian Academy of Sciences); C.A., 103, 123198(1985).Google Scholar
  53. 51.
    Belg. Pat BE 900,225 (Jan. 28, 1985; to Fidia S.p.A.); C.A., 102, 220751 (1985).Google Scholar
  54. 52.
    Ger. Offen. DE 3,324,916 (Jan. 17, 1985; R. Umminger, W. G. Friebe, W Kampe, A. Toesch, and O. H. Wilhelms to Boehringer Mannheim G.m.b.H); C.A., 103, 53815 (1985).Google Scholar
  55. 53.
    U.S. Pat 4,501,755 (Feb. 26, 1985; E. S. Wu to Pennwalt Corp.).Google Scholar
  56. 54.
    Eur. Pat Appl. EP 150,118 (July 31, 1985; J. RokachandR. N. Young to Merck Frosst Canada, Inc.); C.A., 104,130266(1986).Google Scholar
  57. 55.
    Eur. Pat. Appl. EP 150,966 (Aug. 7, 1985; K. J. Gould, J. L. Suschnitzky, and I. D. Dicker to Fisons PLC); C.A., 104, 68836 (1986).Google Scholar
  58. 56.
    Eur. Pat. Appl. EP 151,513 (Aug. 14, 1985; K. K. Schmiegel and H. C. Wilson to Eli Lilly and Co.); C.A., 104, 50682(1986).Google Scholar
  59. 57.
    Brit UK Pat. Appl. GB 2,145,718 (Apr. 3, 1985; C. G. Rimbault to Zyma S.A.); C.A., 104, 50731 (1986).Google Scholar
  60. 58.
    Eur. Pat Appl. EP 146,922 (July 3, 1985; I. Yamazaki and Y. Sawa to Takeda Chemical Industries, Ltd.); C.A., 104, 5774 (1986).Google Scholar
  61. 59.
    Eur. Pat. Appl. EP 150,447 (Aug. 7, 1985; M. Miyano and R. L. Shone to G. D. Searle and Co.); C.A., 104, 5775 (1986).Google Scholar
  62. 60.
    Jpn. Kokai Tokkyo Koho JP 60,009,455 [85,009,455] (Jan. 18, 1985; to Osaka Yakuhin Kenky); C.A., 103, 70127(1985).Google Scholar
  63. 61.
    Eur. Pat Appl. EP 165,897 (Dec. 27, 1985; P. Wenk, A. Sallmann, and A. Beck to Ciba-Geigy A.-G.); C.A., 105, 60408 (1986).Google Scholar
  64. 62.
    Eur. Pat Appl. EP 146,333 (June 26, 1985; J. Goldworthy and J. P. Verge to Lilly Industries, Ltd.); C.A., 103, 215299(1985).Google Scholar
  65. 63.
    U.S. Pat. 4,546,194 (Oct. 8, 1985; M. Miyano, C. I. Villamil, and R. L. Shone to G. D. Searle and Co.).Google Scholar
  66. 64.
    U.S. Pat. 4,546,186 (Oct 8, 1985; M. A. Abou-Gharbia to American Home Products Co.).Google Scholar
  67. 65.
    Eur. Pat Appl. EP 141,608 (May 15, 1985; J. B. Campbell, Jr. and T. M. Bare to ICI Americas, Inc.); C.A., 103, 215280(1985).Google Scholar
  68. 66.
    Ger. Offen. DE 3,329,394 (Feb. 28, 1985; O. S. Wolfbeis and H. Harnisch to Bayer A.-G.). C.A., 103, 22577 (1985).Google Scholar
  69. 67.
    U.S. Pat. 4,540,788 (Sept. 10, 1985; K. C. Murdock to American Cyanamid Co.).Google Scholar
  70. 68.
    Neth. Pat. NL 178,875 (Feb. 1, 1986; to Chinoin Gyogyszer).Google Scholar
  71. 69.
    Ger. Offen. DE 3,528,700 (March 6, 1986; R. F. Newton, D. Middlemiss, A. Naylor, and C. A. Meerholz to Glaxo Group Ltd.); C. A., 105, 42505 (1986).Google Scholar
  72. 70.
    Eur. Pat. Appl. EP 181,125 (May 14, 1986; A. Nohara and Y. Maki to Takeda Chemical Industries, Ltd.); C.A., 105, 97161 (1986).Google Scholar
  73. 71.
    Eur. Pat. Appl. EP 175,541 (March 26, 1986; H. A. Dewald, L. D. Wise, and T. G. Heffner to Warner-Lambert Co.); C.A., 105,133752(1986).Google Scholar
  74. 72.
    U.S. Pat. 4,569,994 (Feb. 11, 1986; R. C. Griffith to Pennwalt Corp.).Google Scholar
  75. 73.
    Ger. Offen. DE 3,619,448 (Dec. 11, 1986; R. Mechoulam and J.J. Feigenbaum to Yissum Research Development Co.; Hebrew University of Jerusalem); C.A., 106, 119347 (1987).Google Scholar
  76. 74.
    Eur. Pat. Appl. EP 200,443 (Apr. 19, 1985; J. G. Atkinson, Y. Guindon, and C. K. Lau to Merck Frosst Canada, Inc.); C.A., 106, 102081 (1987).Google Scholar
  77. 75.
    PCT Int. Appl. WO 86,003,199 (June 5, 1986; G. Sportoletti to Italfarmaco S.p.A.); C.A., 105, 165010(1986).Google Scholar
  78. 76.
    U.S. Pat. 4,594,425 (June 10, 1986; J. Musser and D. M. Kubraka to American Home Products Corp.).Google Scholar
  79. 77.
    U.S. Pat.4,608,370 (Aug. 26, 1986; to R. B. Aronsohn).Google Scholar
  80. 78.
    Jpn. Kokai Tokkyo Koho JP 61,048,511 [86,048,511] (Oct. 28, 1986; K. Kyogoku, K. Hatayama, S. Yokomori, Y. Kawashima, and J. Sawada to Taisho Pharmaceutical Co., Ltd.); C.A., 106, 156148 (1987).Google Scholar
  81. 79.
    Eur. Pat. Appl. EP 175,376 (March 26, 1986; T. Mori, T. Dan, and M. Akima to Chugai Pharmaceutical Co., Ltd.); C.A., 105, 152930 (1986).Google Scholar
  82. 80.
    Ger. (East) DD 244,339 (Apr. 1, 1987; A. Beck, A. Sallmann, R. W. Lang, and P. Wenk to Ciba-Geigy A.-G.); C.A., 108, 37385 (1988).Google Scholar
  83. 81.
    Jpn. Kokai Tokkyo Koho JP 62,181, 276 [87,181,276] (Aug. 8, 1987; T. Hyama and H. Saimoto to Sagami Chemical Research Center); C.A., 108, 37645 (1988).Google Scholar
  84. 82.
    U.S. Pat. 4,686,234 (Aug. 11, 1987; P. H. Nelson, A. C. Allison, and E. M. Engui to Syntex (U.S.A.), Inc.).Google Scholar
  85. 83.
    R. G. Shepherd and A. C. White, J. Chem. Soc., Perkin Trans. 1, 1987(10), 2153.CrossRefGoogle Scholar
  86. 84.
    Ger. Offen. DE 3,522,230 (Jan. 2, 1987; E. Mueller, N. Hauel, K. Noll, B. Narr, J. Heider, M. Psiorz, A. Bomhard, V. J. Meel, and W. Diederen to Dr. Karl Thomae, G.m.b.H.); C.A., 106, 156466 (1987).Google Scholar
  87. 85.
    PCT Int. Appl. WO 87,007,835 (Dec. 30, 1987; T. Sato, H. Matsumoto, and H. Kakegawa to Dainippon Ink Chemical Industry Co.; Nippon Hypox Laboratories, Inc.); C.A., 109, 98856 (1988).Google Scholar
  88. 86.
    U.S. Pat. 4,672,066 (June 9, 1987; M. Carson, L. H. Ru-Jen, and R. A. Mahieu to Hofrmann-LaRoche, Inc.).Google Scholar
  89. 87.
    U.S. Pat. 4,667,055 (May 19, 1987; J. Gillard, J. Rokach, and P. C. Belanger to Merck Frosst Canada, Inc.).Google Scholar
  90. 88.
    PCT Int. Appl. WO 87,005,805 (Oct. 8, 1987; W. A. Saffran, R. L. Edelson, F. P. Gasparro, J. T. Welsh, and C. R. Cantor to Columbia University); C.A., 109, 149352 (1988).Google Scholar
  91. 89.
    D. W. Robertson and J. H. Krushinski, Org. Prep. Proc. Int., 20(3), 311 (1988), and references cited therein.CrossRefGoogle Scholar
  92. 90.
    Eur. Pat. Appl. EP 276,065 (July 27, 1988; N. G. Bollinger, T. Goodson, Jr., and D. K. Herron to Eli Lilly and Co.); C.A., 109, 230544 (1988).Google Scholar
  93. 91.
    Eur. Pat. Appl. EP 292,977 (Nov. 30, 1988; S. W. Djuric, R. L. Shone, and S. S. T. Yu to G. D. Searle and Co.); C.A., 110, 174088 (1989).Google Scholar
  94. 92.
    PCT Int. Appl. WO 88,004,654 (June 30, 1988; H. O. J. Hall and S. O. Thorberg to Astra Laekmede AB); C.A., 109, 210900 (1988).Google Scholar
  95. 93.
    Indian Pat. IN 163,780 (Nov. 5, 1988; to R. J. Kumar, L. D. K. Gazula, and G. Srimannarayana); C.A., 112, 158226 (1990).Google Scholar
  96. 94.
    Eur. Pat. Appl. EP 288,202 (Oct. 26, 1988; H. W. R. Williams and R. N. Young to Merck Frosst Canada, Inc.); C.A., 110, 114450 (1989).Google Scholar
  97. 95.
    U.S. Pat. 4,758,597 (July 19, 1988; A. R. Martin, P. F. Conroe, and V. J. Shah to University Patents, Inc.).Google Scholar
  98. 96.
    Ger. Offen. DE 3,735,990 (Apr. 28, 1988; R. Mechoulam, J. Feigenbaum, M. Srebnik, and N. Lander to Yissum Research and Development Co.); C.A., 110, 154614 (1989).Google Scholar
  99. 97.
    Eur. Pat. Appl. EP 293,146 (Nov. 30, 1988; Y. Konoshita, S. Ikeguchi, N. Tsutsumi, Y. Ajisawa, and A. Ujiie to Kissei Pharmaceutical Co., Ltd.); C.A., 110, 114818 (1984).Google Scholar
  100. 98.
    U.S. Pat. 4,839,364 (June 13, 1989; G. M. Shutske and F. A. Pierrat to Hoechst-Roussel Pharmaceuticals, Inc.).Google Scholar
  101. 99.
    Ger. Offen. DE 3,741,224 (June 22, 1989; R. Sobotta, A. Langbein, H. Merz, and R. Bauer to Boehringer Ingelheim K.G.); C.A., 112, 35688 (1990).Google Scholar
  102. 100.
    Ger. Offen. DE 3,808,136 (Sept. 21, 1989; E. Mueller, J. Nikl, A. Heckel, and G. Engelhardt to Dr. Karl Thomae, G. m. b. H.); C.A., 112, 138919 (1990).Google Scholar
  103. 101.
    Jpn. Kokai Tokkyo Koho JP 01,242,580 [89,242,580] (Sept. 27, 1989; K. Hiraga, M. Goto, K. Inoue, and M. Ichida to Nippon Nohyaku Co., Ltd.); C.A., 112, 158230 (1990).Google Scholar
  104. 102.
    Jpn. Kokai Tokkyo Koho JP 01,121,236 [89,121,236] (May 12, 1989; M. Shimizu, K. Inoe, H. Kohama, H. Oonishi, and M. Sugyama to Terumo Corp.); C.A., 111, 194305 (1989).Google Scholar
  105. 103.
    U.S. Pat. 4,806,660 (Feb. 21, 1989; E. S. Wu to Pennwalt Corp.).Google Scholar
  106. 104.
    Eur. Pat. Appl. EP 300,404 (Jan. 25, 1989; M. Miyano, M. A. Stealy, and R. L. Shone to G. D. Searle and Co.); C.A., 111, 96867 ((1989).Google Scholar
  107. 105.
    Jpn. Kokai Tokkyo Koho JP 01,197,436 [89,197,436] (Aug. 9, 1989; M. Shimizu, S. Myoka, H. Oonishi, K. Inoe, and M. Sugyama to Terumo Corp., Ltd.); C.A., 112, 55238 (1990).Google Scholar
  108. 106.
    PCT Int. Appl. WO 89,005,289 (June 15, 1989; I. Tomino, M. Ishiguro, T. Kitahar, K. Yokoyama, N. Kihara, J. Kamiya, K. Yoshihara, M. Ishii, and A. Mizuchi to Mitsui Petrochemical Industries, Ltd.; Mitsui Pharmaceuticals, Inc.); C.A., 112, 55583 (1990).Google Scholar
  109. 107.
    Brit. UK Pat. Appl. GB 2,211,500 (July 5, 1989; I. N. H. White to Medical Research Council); C.A., 112, 55607(1990).Google Scholar
  110. 108.
    U.S. Pat. 4,820,726 (Apr. 11, 1989; A. Beck, A. Sallmann, R. W. Lang, and P. Wenk to Ciba-Geigy Corp.).Google Scholar
  111. 109.
    Ger. Offen. DE 3,904,731 (Aug.24, 1989; K. Kasai, S. Tokutake, and N. Yamaji to Kikkoman Corp.); C.A., 112, 56578 (1990).Google Scholar
  112. 110.
    Eur. Pat. Appl. EP 306,959 (March 15, 1989; M. Ohashi, K. Awano, T. Tanaka, and T. Kimura to Kyorin Pharmaceutical Co., Ltd.); C.A., 111, 133788 (1989).Google Scholar
  113. 111.
    Jpn. Kokai Tokkyo Koho JP01,294,660 [89,294,660] (Nov. 28, 1989; H. Yamamoto and K. Shiraki to Yamanouchi Pharmaceutical Co., Ltd.); C.A., 112, 198843 (1990).Google Scholar
  114. 112.
    Eur. Pat. Appl. EP 297,651 (Jan. 4, 1989; H. H. Haeck, D. Hamminga, I. Van Wijngaarden, and W Wouters to Duphar International Research, B.V.); C.A., 110, 212631 (1989).Google Scholar
  115. 113.
    U.S. Pat. 4,857,659 (Aug. 15, 1989; R. Frenette, J. Y. Gauthier, R. N. Young, R. Zamboni, M. Kakushima, and T. R. Verhoeven to Merck Frosst Canda, Inc.).Google Scholar
  116. 114.
    Eur. Pat. Appl. EP 342,665 (Nov. 23, 1989; T. Kanamuru, T. Hida, and M. Muroi to Takeda Chemical Industries, Ltd.); C.A., 113, 5954 (1990).Google Scholar
  117. 115.
    Eur. Pat. Appl. EP 360,566 (March 28, 1990; M. Nakane, T. Kokura, and F. Ito to Pfizer, Inc.); C.A., 113, 132163 (1990).Google Scholar
  118. 116.
    U.S. Pat. 4,937,260 (June 26, 1990; T. DePaulis, S. I. Raemsby, and S. O. Oegren to Astra Laekemedal AB).Google Scholar
  119. 117.
    U.S. Pat. 4,945,099 (July 31, 1990; N. G. Bollinger, T. Goodson, Jr., and D. K. Herron to Eli Lilly and Co.).Google Scholar
  120. 118.
    Eur. Pat. Appl. EP 372,962 (June 13, 1990; I. T. Forbes, R. T. Martin, and M. Thompson to Beecham Group PLC); C.A., 114, 6486 (1991).Google Scholar
  121. 119.
    Jpn. Kokai Tokkyo Koho JP 02,191,269 [90,191,269] (July 27, 1990; H. Nakayama, M. Ishikura, Y. Ueda, K. Imai, M. Terajima, and A. Suzui to Toyo Pharmaceutical Co., Ltd.; Daiso Co., Ltd.); C.A., 113, 211845(1990).Google Scholar
  122. 120.
    Eur. Pat. Appl. EP 374,513 (June 27, 1990; A. Wissner, K. Green, and R. E. Schaub to American Cyanamid Co.); C.A., 113, 212346 (1990).Google Scholar
  123. 121.
    Eur. Pat. AppL EP 341,664 (Nov. 15, 1990; S. Torihara, Y. Tamai, M. Shiono, and K. Tasaka to Kuraray Ltd.); C.A., 113, 178024 (1990).Google Scholar
  124. 122.
    USSR SU 1,560,215 (Apr. 30, 1990; A. I. Grudnayov to Central Scientific-Research Institute of Stomatology); C.A., 113, 178290(1990).Google Scholar
  125. 123.
    Jpn. Kokai Tokkyo Koho JP 02,172,916 [90,172,916] (July 4, 1990; T. Shishido and H. Okada to Fuji Photo Film Co., Ltd.); C.A., 114, 101980 (1991).Google Scholar
  126. 124.
    U.S. Pat. 4,920,131 (Apr. 24, 1990; F.-C. Huang, R. A. Galemmo, Jr., and H. F. Campbell to Rorer Pharmaceutical Corp.).Google Scholar
  127. 125.
    Israeli Pat. IL 80,080 (Sept. 17, 1990; to F. Hoffmann-LaRoche and Co., A.-G.); C.A., 115, 92072 (1991).Google Scholar
  128. 126.
    U.S. Pat. 4,996,230 (Feb. 26, 1991; D. M. Gapinski to Eli Lilly and Co.).Google Scholar
  129. 127.
    Jpn. Kokai Tokkyo Koho JP 02,292,213 [90,292,213] (Dec. 3, 1990; H. Tamai, T. Yamane, and K. Tasaka to Kuraray Co., Ltd.); C.A., 114, 157192 (1991).Google Scholar
  130. 128.
    Eur. Pat. Appl. EP 411,912 (Feb. 5,1991; H. Yanagisawa, K. Fujimoto, Y Shimoji, and T. Kanazaki to Sankyo Co., Ltd.); C.A., 115, 71396 (1991).Google Scholar
  131. 129.
    Jpn. Kokai Tokkyo Koho JP 03,068,551 [91,068,551] (March 25, 1991; S. Takahashi to Seiko Instruments and Electronics, Ltd.); C.A., 115, 72228 (1991).Google Scholar
  132. 130.
    Eur. Pat. Appl. EP412,803 (Feb. 13, 1991; S. Yakomori, K. Saijo, T. Matsunaga, Y Nakashima, and K. Hatayama to Taisho Pharmaceutical Co., Ltd.); C.A., 115, 8321 (1991).Google Scholar
  133. 131.
    PCT Int. Appl. WO 91,017,160 (Nov. 14, 1991; S. W. Djuric, T. D. Penning, and J. P. Snyder to G. D. Searle and Co.); C.A., 116, 83676 (1992).Google Scholar
  134. 132.
    Jpn. Kokai Tokkyo Koho JP 03,068,549 [91,068,549] (March 25, 1991; T. Mase, Y. Ishii, K. Tomioka, and Y. Soeishi to Yamanouchi Pharmaceutical Co., Ltd.); C.A., 115, 92274 (1991).Google Scholar
  135. 133.
    Eur. Pat. Appl. EP 419,411 (March 27, 1991; A. Von Sprecher, B. Schaub, and R. W. Lang to Ciba-Geigy A.-G.); C.A., 115, 114351 (1991).Google Scholar
  136. 134.
    PCT Int. App. WO 91,005,757 (May 2, 1991; N. Y Shih and P. Mangiaracina to Schering Corp.); C.A., 115, 114147(1991).Google Scholar
  137. 135.
    Jpn. Kokai Tokkyo Koho JP 03,068,516 [91,068,516] (March 25, 1991; S. Sato M. Chin, H. Mihashi, and T. Nomura to Tsumura and Co., Ltd.); C.A., 115, 182941 (1991).Google Scholar
  138. 136.
    Jpn. Kokai Tokkyo Koho JP 03,115,287 [91,115,287] (May 16, 1991; to Fujisawa Pharmaceutical Co, Ltd.; Colorado State University Research Foundation); C.A., 115, 183332 (1991).Google Scholar
  139. 137.
    Jpn. Kokai Tokkyo Koho JP 03,127,783 [91,127,783] (May 30, 1991; H. Yanasigawa, K. Fujimoto, Y. Shimoji, T. Kanezaki, N. Iwata, and Y. Kubo to Sankyo Co., Ltd.); C.A., 115, 232261 (1991).Google Scholar
  140. 138.
    Eur. Pat. Appl. EP 421,829 (Apr. 10, 1991; S. Samreth, V. Barberousse, P. Renaut, F. Bellamy, and J. Millet to Fournier Innovation et Synergie); C.A., 115, 256557 (1991).Google Scholar
  141. 139.
    U.S. Pat. 4,996,230 (Feb. 26, 1991; D. M. Gapinski to Eli Lilly and Co.).Google Scholar
  142. 140.
    Fr. Demande FR 2,653,996 (May 10, 1991; to Armando Lourenco); C.A., 115, 239319 (1991).Google Scholar
  143. 141.
    Jpn. Kokai Tokkyo Koho JP 03,284,612 (Dec. 16, 1991; H. Shibata, Y Minosasa, K. Matsui, H. Uehara, and H. Tanaka to Naris Cosmetics Co., Ltd.); C.A., 116, 214752 (1992).Google Scholar
  144. 142.
    Jpn. Kokai Tokkyo Koho JP 03,287,589 [91,287,589] (Dec. 18, 1991; Y Yokokawa, M. Yoshida, K. Umishio, and K. Uehara to Shiseido Co., Ltd.); C.A., 116, 214698 (1992).Google Scholar
  145. 143.
    Jpn. Kokai Tokkyo Koho JP 03,287,587 (Dec. 18, 1991; T. Mase, Y. Kondo, H. Nagaoka, T. Yamada, and K. Tomioka to Yamanouchi Pharmaceutical Co., Ltd.); C.A., 116, 255603 (1992).Google Scholar
  146. 144.
    Jpn. Kokai Tokkyo Koho JP 04,001,116 [92,001116] (Jan. 6, 1992; T. Hamazaki, M. Matsugami, M. Takenochi, K. Utsugi, and H. Nakano to Pola Chemical Industries, Inc., Ltd.); C.A., 116, 180944 (1992).Google Scholar
  147. 145.
    PCT Int. Appl. WO 92,000,011 (Jan. 9, 1992; S. W. Djuric, S. H. Docter, and S. S. T. Yu to G. D. Searle and Co.); C.A., 116, 214350 (1992).Google Scholar
  148. 146.
    PCT Int. Appl. WO 92,000,285 (Jan. 9,1992; Y Yoshimoto, S. Yasufuku, Y. Mikita, K. Inoue, and K. Nakanouchi to Nippon Shinyaku Co., Ltd.); C.A., 116, 214505 (1992).Google Scholar
  149. 147.
    Jpn. Kokai Tokkyo Koho JP 04,054,179 [92,054,179] (Feb. 21, 1992; J. Imuda, N. Kihara, A. Mizuchi, K. Horigome, and A. Awaya to Mitsui Sekiyu Kagaku Kogyo K. K.; Mitsui Seiyaku K. K.); C.A., 117, 69731 (1992).Google Scholar
  150. 148.
    PCT Int. Appl. WO 92,006,075 (April 16, 1992; K. W. Franzmann to Wellcome Foundation Ltd.); C.A., 117, 48124 (1992).Google Scholar
  151. 149.
    Jpn. Kokai Tokkyo Koho JP 04,187,632 [92,187,632] (July 6, 1992; H. Suzuki, T. Nishimura, H. Yamaki, H. Yamaguchi, N. Tanaka, and T. Takeuchi to Microbiochemical Research Foundation); C.A., 117, 169501 (1992).Google Scholar
  152. 150.
    Jpn. Kokai Tokkyo Koho JP 04,134,048 [92,134,048] (May 7, 1992; T. Ishimaru, S. Tsuboya, H. Shirafuji, and Z. Terashita to Takeda Chemical Industries, Ltd.); C.A., 117, 178329 (1992).Google Scholar
  153. 151.
    Jpn. Kokai Tokkyo Koho JP 04,112,884 [92,112,884] (Apr. 14, 1992; T. Yoshioka, R. Miyata, H. Tone, R. Okamoto, H. Kumagai, M. Ishizuka, and T. Takeuchi to Merican Corp., Ltd.); C.A., 117, 171087 (1992).Google Scholar
  154. 152.
    Jpn. Kokai Tokkyo Koho JP 04,154,773 [92,154,773] (May 27, 1992; N. Sugiyama, T. Goto, T. Okano, Y. Yamaura, F. Akaboshi, S. Ono, H. Yoshitomi, Y. Naito, and T. Fukaya to Green Cross Corp.); C.A., 117, 212486 (1992).Google Scholar
  155. 153.
    PCT Int. Appl. WO 92,011,252 (July 9, 1992; S. W. Djuric, D. J. Fretiand, and S. S. T. Yu to G. D. Searle and Co.); C.A., 117, 234018 (1992).Google Scholar
  156. 154.
    PCT Int. Appl. WO 92,010,096 (June 25, 1992; R. D. Sindelar, B. J. Bradbury, T. S. Kaufman, S. H. Ip, H. C. March, Jr., and C. Lee to T. Cell Sciences, Inc.; University of Mississippi); C.A., 117, 251233 (1992).Google Scholar
  157. 155.
    Eur. Pat. Appl. EP 495,485 (July 22, 1992; M. Ohashi, T. Tanaka, N. Ishikawa, and T. Kishi to Kyorin Pharmaceutical Co., Ltd.); C.A., 117, 233602 (1992).Google Scholar
  158. 156.
    Jpn. Kokai Tokkyo Koho JP 03,169,811 [91,169,811] (July 23, 1991; K. Miyasaki and S. Saigo to Otsuka Pharmaceutical Co., Ltd.); C.A., 116, 67191 (1992).Google Scholar
  159. 157.
    Jpn. Kokai Tokkyo Koho JP 03,275,687 [91,275,687] (Dec. 6, 1991; H. Tsuchida, T. Komatsu, E. Hasegawa, and H. Nishide to Zaidan Hojin Seisan Kaihatsu Kagaku Kenkyusho; Nippon Oil and Fats Co., Ltd.); C.A., 117, 90050 (1992).Google Scholar
  160. 158.
    Jpn. Kokai Tokkyo Koho JP 03,294, 273 [91,294,273 (Dec. 25, 1991; T. Akiyama, K. Ichikawa, Y. Matsui, and H. Haruyama to Sankyo Co., Ltd.); C.A., 116, 22211551 (1992).Google Scholar
  161. 159.
    Jpn. Kokai Tokkyo Koho JP 04,169,511 [92,169,511] (June 17, 1992; M. Noda, K. Matsuda, M. Takenochi, N. Satooka, T. Yamane, M. Torihara, and H. Tamai to Pola Chemical Industries, Inc.; Kuraray Co., Ltd.); C.A., 117, 220114 (1992).Google Scholar
  162. 160.
    Jpn. Kokai Tokkyo Koho JP 04,221,393 [92,221,393] (Aug. 11, 1992; K. Kasai, K. Okada, and N. Yamatsugu to Kikkoman K. K.); C.A., 118, 124963 (1993).Google Scholar
  163. 161.
    Jpn. Kokai Tokkyo Koho JP 04,217,678 [92,217,678] (Aug. 7, 1992; Y. Tsuchiya, H. Masaki, T. Sato, and T. Kamei to Banyu Pharmaceutical Co., Ltd.); C.A., 118, 168980 (1993).Google Scholar
  164. 162.
    PCT Int. Appl. WO 92,013,852 (Aug. 20, 1992; H. Takagaki, M. Sakai, H. Takahashi, K. Inazawa, M. Abe, and N. Kimura to Dainippon Ink Chemical Industry Co., Ltd.); C.A., 119, 8681 (1993).Google Scholar
  165. 163.
    Jpn. Kokai Tokkyo Koho JP 04,282,380 [92,282,380] (Oct. 7, 1992; Y. Shida, T. Akama, S. Ikeda, M. Kasai, S. Kandori, Y. Hirayama, H. Ishida, and K. Gomi to Kyowa Hakko Kogyo Co., Ltd.); C.A., 119, 8593 (1993).Google Scholar
  166. 164.
    Jpn. Kokai Tokkyo Koho JP 04,266,848 [92,266,848] (Sept. 22, 1992; H. Kawagishi, F. Kojima, H. Sakamoto, T. Yoshida, and Y. Ishiguro to Kagome Co., Ltd.); C.A., 118, 66842 (1993).Google Scholar
  167. 165.
    Eur. Pat. Appl. EP 512,525 (Nov. 11, 1992; Y. Oshiro, T. Tanaka, T. Kikuchi, and K. Tottori to Otsuka Pharmaceutical Co., Ltd.); C.A., 118, 101983 (1993).Google Scholar
  168. 166.
    PCT Int. Appl. WO 92,022,545 (Dec. 23, 1992; A. Romeo and M. Prosdocimi to Fidia S.p.A.); C.A., 118, 212 892(1993).Google Scholar
  169. 167.
    A. Wissner, M. L. Carrol, K. E. Green, S. S. Kerwar, W. C. Pickett, R. E. Schaub, L. W. Torley, S. Wrenn, and C. A. Kohler, J. Med. Chem., 35(9), 1650 (1992).CrossRefGoogle Scholar
  170. 168.
    PCT Int. Appl. WO 93,000,080 (Jan. 7, 1993; M. K. Ellis, S. T. Lindstedt, E. A. Lock, M. E. H. Maj, L. C. Mutter, and M. P. Prisbylla to Imperial Chemical Industries PLC); C.A., 118, 94329 (1993); see also: Chem. Brit., 29, 10 (1993).Google Scholar
  171. 169.
    C. N. Lin, S. S. Liou, F. N. Ko, and C. M. Teng, J. Pharm. Sci., 82(1), 11 (1993); CA., 118, 212814 (1993).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Hans Dressler
    • 1
  1. 1.Formerly of INDSPEC Chemical CorporationPittsburghUSA

Personalised recommendations